Dr Godwin Aleku is a Lecturer in Drug Discovery within the School of Cancer and Pharmaceutical Sciences at King's College London.

Godwin worked initially as a clinical pharmacist with focus on infectious diseases and later as a senior regulatory affairs officer with the (Nigerian) National Agency for Food and Drug Administration and Control. He moved to the UK as a postgraduate student and completed an MSc in Biotechnology and Enterprise in 2013 at the University of Exeter.

Godwin obtained a PhD in Chemical Biology in 2017, working with Professor Nicholas Turner FRS at the University of Manchester. He was a postdoctoral research associate at the Manchester Institute of Biotechnology between 2017 and early 2020, in the group of Professor David Leys. Godwin was an EMBO New Venture Fellow spending 3 months with Professor Roland Riek's lab at ETH Zurich. In mid-2020, he moved to the University of Cambridge where he was a Leverhulme/Isaac Newton Trust Early Career Research Fellow at the Department of Biochemistry and a Junior Research Fellow at Wolfson College, Cambridge.

Godwin joined King's College in November 2022; he leads an interdisciplinary research focusing on the development of clean enzyme-based sustainable pharmaceutical synthesis methods and the application of biocatalysis in drug discovery. His research employs multidisciplinary techniques including biocatalysis, organic synthesis, pharmacological screening, enzyme engineering, biochemistry, molecular biology, high-throughput assay development and industrial biotechnology.

For a list of research publications, visit Godwin's PURE page here.